Knight Therapeutics Inc (FRA:04K)
€ 3.42 -0.36 (-9.52%) Market Cap: 354.19 Mil Enterprise Value: 277.97 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 88/100

Q1 2022 Knight Therapeutics Inc Earnings Call Transcript

May 12, 2022 / 12:30PM GMT
Release Date Price: €3.78 (-2.58%)
Operator

Good morning, ladies and gentlemen. My name is Chad, and I will be your operator today. Welcome to Knight Therapeutics Inc. First Quarter 2022 Results Conference Call.

Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time that they were prepared, but cautious that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries, may ultimately prove to be incorrect.

The company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events, except as required by law. We would also like to remind you questions during today's call will be taken from analysts only. Should there be any

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot